Meta-analysisindependent cross-checkabstract only checked I-WHT-02 standard review

Refined grains and heart disease (industry-linked author)

Refined grain intake and cardiovascular disease: Meta-analyses of prospective cohort studies.

Overview

Gaesser GA. Trends Cardiovasc Med 2024 · PMID 36075506 · DOI 10.1016/j.tcm.2022.08.002

Pooled cohorts showed no clear link between refined grains and heart disease.

Does the study support the specific claim? No · Methodological quality: low

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Refined grains and CVD

How was the study done?

Meta-analysis

How many people, animals or samples were studied?

17 cohorts

What was actually found?

No association

How large was the observed effect?

HR 1.08 (ns)

What do the results mean in everyday life?

Moderate refined grains not clearly harmful

What are the study's limitations?

COI, heterogeneity

What does it say about Elawady's specific claim?

Limits harm claim

Do the results apply to Germany and Europe?

Moderate

What can explicitly not be concluded from this study?

Benefit of refined grains

Scientific in-depth review

1. Full reference

Authors
Gaesser GA
Journal
Trends Cardiovasc Med
Year
2024
Identifier
PMID 36075506 DOI 10.1016/j.tcm.2022.08.002
Verification
verified – PubMed efetch 2026-10-25
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

Not stated in the PubMed record. The same author disclosed grant support from the Wheat Foods Council and Grain Foods Foundation and advisory board roles (Grain Foods Foundation, Wheat Foods Council, Ardent Mills) in a 2019 review (PMID 30947337, PMC full text read).

2. Research question

Refined grains (as a distinct category) and CVD

3. Study design and population

Study design
Meta-analysis – Meta-analysis of prospective cohorts
Population

Cohort participants

Country

Multiple

Period

Search to 30 June 2022

Sample size

17 cohorts, >875,000 participants

Inclusion and exclusion criteria

Refined grains as distinct category only

4. Methods and endpoints

Exposure / intervention

Refined grains; white rice

Comparator

Lowest

Endpoints

CVD, stroke, heart failure

Statistical methods

RevMan random effects

5. Actual results

Results

Refined grains: CVD HR 1.08 (0.99-1.18; I2 70%; 9 cohorts); stroke 1.06 (0.92-1.23); heart failure 0.95 (0.77-1.16). White rice: CVD 0.93 (0.86-1.00); stroke 1.03 (0.93-1.14). No publication bias evident.

Absolute risks

not reported

Authors' conclusion

Refined grains not associated with CVD; consider in future guidelines.

6. Strengths

  • Restricts to refined grains as separate category

7. Weaknesses

  • Single author
  • Likely industry links
  • High heterogeneity

8. Risk of bias

Orienting tool
AMSTAR 2
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
high
Rationale

Single-author review; COI concern.

9. Assessment of the statistical interpretation

Null CIs include modest increases.

10. Relevance to the specific claim

Counter-evidence for C-WHT-03, but with COI concern.

11. Independent contrary findings

12. Transferability to Germany and Europe

Moderate.

13. Overall methodological judgement

Useful but should be weighted cautiously.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitylow
Risk of biashigh
Precision of resultsmoderate
Directnessdirect
Reproducibilitypartly replicated
Consistency with the overall evidencemixed
Regional transferabilitymoderate
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Full COI for this paper.

15. Linked fact checks